Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Response to hepatitis A and B vaccine among immunosuppressed children
2008-003280-40Phase 4Completed
- Sponsor
- Public Health Service of Amsterdam
- Start
- Feb 2009
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of hepatitis a vaccine + hepatitis b vaccine in hepatitis A (HAV) and hepatitis B (HBV) (2 arms), sponsored by Public Health Service of Amsterdam. Primary endpoints: Serologic response to Ambirix and Association between immunosuppression degree and vaccine response. Started Feb 2009; status: completed.
02
Drugs
hepatitis a vaccine + hepatitis b vaccine
03
Conditions
hepatitis A (HAV)hepatitis B (HBV)
Beyond the preview
Go deeper on 2008-003280-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003280-40.